sábado, 14 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 28, 2026

Adobe’s AI growth takes center stage after guidance raise

View original at finance.yahoo.com
Adobe’s AI growth takes center stage after guidance raise This quarter made one thing clear. Adobe’s (ADBE) AI story now has real revenue behind it…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The CEO transition is a natural handoff after nearly two decades, framed as entering a new era of creativity being written right now

    60% confidence
  • Adobe faces pressure on high-end users and has limited exposure to lower-priced tiers where demand is growing faster

    60% confidence
  • Management pointed to solid retention, upsell, and paid conversion trends across Creative Cloud and Document Cloud

    60% confidence
  • Adobe faces weaker-than-expected net new ARR and pressure on pricing as freemium AI tools expand usage but weigh on ARPU

    60% confidence
  • Investors will likely focus on whether incoming leadership maintains balance between disciplined execution and aggressive AI investment

    60% confidence
  • The next era of creativity is being written right now, suggesting new leadership is needed to guide that next chapter

    60% confidence
  • Adobe's business remains stable but faces concerns around pricing power, competitive pressure, and CEO transition uncertainty

    60% confidence

Data points we hold from this source

Adobe Inc. · enterprise value97.1 USD
Adobe Inc. · forward pe ratio10.0 ratio
Adobe Inc. · ytd stock performance-37 percent
Adobe Inc. · analyst avg price target328.19 USD
Adobe Inc. · ai arr125 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Adobe’s AI growth takes center stage after guidance raise — Source | Via News | es.VIA.NEWS